Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bradley, Walsh"'
Autor:
Dhanusha Sabanathan, Douglas Campbell, Vicki Velonas, Sandra Wissmueller, Hubert Mazure, Marko Trifunovic, Pirooz Poursoltan, Kevin Ho-Shon, Tiffany Mackay, Maria Lund, Yanling Lu, Paul Roach, Dale Bailey, Bradley Walsh, David Gillatt, Howard Gurney
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 9, Iss 2, Pp 86-100 (2021)
Objective(s): Miltuximab® is a chimeric antibody targeting Glypican-1 (GPC-1), a cell surface antigen which is overexpressed in solid cancers. Miltuximab® has shown promising safety and efficacy in radioimmunotherapy models of prostate cancer. This
Externí odkaz:
https://doaj.org/article/e54133442db347f2aa83af2e911eee7d
Autor:
Dale Bailey, Dhanusha Sabanathan, Alireza Aslani, Douglas Campbell, Bradley Walsh, Nigel Lengkeek
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 9, Iss 1, Pp 1-8 (2021)
A limitation to the wider introduction of personalised dosimetry in theranostics is the relative paucity of imaging radionuclides with suitable physical and chemical properties to be paired with a long-lived therapeutic partner. As most of the beta-e
Externí odkaz:
https://doaj.org/article/d5a8c57c6642420fa655fef00a9b4b2d
Autor:
Saikat Ghosh, Pie Huda, Nicholas L. Fletcher, Christopher B. Howard, Bradley Walsh, Douglas Campbell, Mark B. Pinkham, Kristofer J. Thurecht
Publikováno v:
Molecular pharmaceutics. 19(5)
Glioblastoma (GB) is recognized as the most aggressive form of primary brain cancer. Despite advances in treatment strategies that include surgery, radiation, and chemotherapy, the median survival time (∼15 months) of patients with GB has not signi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68f15dc2b241c79e22c8abad5102ce1
https://pubmed.ncbi.nlm.nih.gov/35438509
https://pubmed.ncbi.nlm.nih.gov/35438509
Autor:
Saikat Ghosh, Pie Huda, Nicholas Fletcher, Douglas Campbell, Kristofer J. Thurecht, Bradley Walsh
Publikováno v:
Expert opinion on biological therapy. 22(5)
Glypican-1 (GPC-1) is a heparan sulfate proteoglycan (HSPG) overexpressed in multiple cancers. Multiple studies indicate the prominence of this cancer biomarker with significant diagnostic and therapeutic potential. Recent advances in monoclonal anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66a72a06c7a6527e9abd1e178cb6202d
https://pubmed.ncbi.nlm.nih.gov/35067148
https://pubmed.ncbi.nlm.nih.gov/35067148
Autor:
Neal D. Shore, Christopher Michael Pieczonka, R. Jonathan Henderson, James L. Bailen, Daniel R. Saltzstein, Raoul S. Concepcion, David Gillatt, Daniel W. Chan, Douglas Campbell, Yanling Lu, Thao Ho Le, Niantao Deng, Bradley Walsh
Publikováno v:
Journal of Clinical Oncology. 40:229-229
229 Background: Clinicians want a more accurate diagnostic test to identify patients for prostate biopsy. We have previously described the development of a Luminex based test for aggressive prostate cancer (MiCheck). To facilitate widespread deployme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::415377445881303a15909ece5a249d48
https://doi.org/10.1200/jco.2022.40.6_suppl.229
https://doi.org/10.1200/jco.2022.40.6_suppl.229
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 519
Identification and characterization of proteins are ultimately the goal in proteomic analysis. In order to identify a protein trypsin is commonly used to digest protein into peptides which can be analyzed by matrix-assisted laser desorption ionizatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf1ef4856796daa7e1ee820c108f5eb8
https://pubmed.ncbi.nlm.nih.gov/19381606
https://pubmed.ncbi.nlm.nih.gov/19381606
Autor:
Evans, Victoria, BOptom, Victoria Evans, Vockler, Cassandra, Fracp, Michael Friedlander PhD, PhD, Bradley Walsh, PhD, Mark Dp Willcox
Publikováno v:
Clinical & Experimental Ophthalmology; Jun2001, Vol. 29 Issue 3, p161-163, 3p